CRNX Award Disclosure
Schilke Tobin · SEC Form 4 · Filed Aug 24, 2026
Award
Calculated transaction value
$0
Schilke Tobin Chief Financial & Infra. Ofcr.
CRNX
Transaction date
Aug 20, 2026
Public filing date
Aug 24, 2026
Filing lag
Filed 4 days later
CRNX daily price context
Close on/before transaction
$84.69
Aug 20, 2026
Close before public filing
$84.69
Aug 21, 2026
Return since public filing
+0.31%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 471 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001628280-26-058664
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. CRNX Current | Award | Aug 20, 2026 | $0 |